Results
1 -
10 of
134K. Ravikumar, B. Sridhar and H. Krishnan.
Zolmitriptan, an antimigraine drug, Acta Cryst. (2007). E63, o1774-o1776Â Â Â Â G. Y. S. K. Swamy, B. Sridhar, K. Ravikumar and H. Krishnan.
The 1:1 inclusion compounds zolmitriptan-benzene and zolmitriptan-phenol, Acta Cryst. (2007). C63, o437-o440Â Â Â Â Antimigraine drugs, Journal of Neurology The novel anti-migraine compound zolmitriptan (Zomig 311C90) has no clinically significant interactions with paracetamol or metoclopramide, European Journal of Clinical Pharmacology Newly Approved Agents for the Treatment and Prevention of Pediatric Migraine, CNS Drugs Acute Treatment for Primary Headache Disorders in Children, Pharmacological Management of Headaches Pharmacological Treatment of Acute Migraine in Adolescents and Children, Pediatric Drugs Consider the risk of potential drug interactions when co-prescribing triptans with other medications, Drugs & Therapy Perspectives The Zolmitriptan-Pyridine (1:1) and Zolmitriptan-Propiophenone (3:2) Inclusion Complex, Journal of Chemical Crystallography Duel-Acting Subcutaneous Microemulsion Formulation for Improved Migraine Treatment with Zolmitriptan and Diclofenac: Formulation and In Vitro-In Vivo Characterization, The AAPS Journal